ABC
HAE icon

Associated Banc-Corp’s Haemonetics HAE Stock Holding History

Associated Banc-Corp’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11
Closed -$1K – 546
2020
Q4 		$1K Hold
11
– – ﹤0.01% 919
2020
Q3 		$1K Buy
+11
New +$961 ﹤0.01% 876
2020
Q2 		– Sell
-22
Closed -$2K – 1026
2020
Q1 		$2K Buy
+22
New +$2.39K ﹤0.01% 585

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Associated Banc-Corp's HAE Position: Q1 2021 in Review

Associated Banc-Corp sold out of Haemonetics (HAE) in Q1 2021, closing a stake of 11 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in HAE in Q1 2020 and held it in 3 quarters. The position peaked at $2K in Q1 2020. 296 funds tracked by Wall St. Rank hold HAE as of Q1 2021.

  • Associated Banc-Corp reported no remaining Haemonetics position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 11 Haemonetics shares in Q1 2021, an estimated $1K.
  • Associated Banc-Corp first reported a position in Haemonetics in Q1 2020 and held it in 3 quarters.
  • Associated Banc-Corp's Haemonetics position peaked at $2K in Q1 2020.
  • 296 funds tracked by Wall St. Rank held Haemonetics as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.